Compared with the model group, different concentrations of oat and bran treatment groups could promote the expression of IL-10 and inhibit the gene expression of IL-6 and TNF-α, thus mitigating the mucosal damage caused by DSS-induced colitis. The gene discussed is IL6; the disease is colitis.